Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 30, Issue 6, 2012, Pages 843-849

  Cay, H F ^a   Sezer, I ^a   Dogan, S ^b   Felek, R ^b   Aslan, M ^b  

^a ANTALYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Myeloperoxidase; Nitrotyrosine; Sj gren's syndrome; Tumour necrosis factor alpha

Indexed keywords

3 NITROTYROSINE; GLUTATHIONE; MYELOPEROXIDASE; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NITRATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SJOEGREN SYNDROME; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITRATES; NITRITES; ODDS RATIO; PEROXIDASE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; UP-REGULATION;

EID: 84872719070     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DANILES T: Sjögren's syndrome. In KLIPPEL JH (Ed.): Primer on the Rheumatic Diseases. NewYork, Springer, 2008: 389-96.
2. FOX RI: Sjögren's syndrome. Lancet 2005; 366: 321-31.
3. COBB BL, LESSARD CJ, HARLEY JB, MOSER KL: Genes and Sjögren's syndrome. Rheum Dis Clin North Am 2008; 34: 847-68.
4. VENABLES PJ: Sjögren's syndrome: Best Pract Res Clin Rheumatol 2004; 18: 313-29
5. WILLEKE P, SCHOTTE H, SCHLÜTER B et al.: Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome. Ann Rheum Dis 2003; 62: 359-62.
6. MATSUMURA R, UMEMIYA K, KAGAMI M et al.: Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sjögren's syndrome. Clin Exp Rheumatol 2002; 20: 791-8.
7. PERTOVAARA M, HULKKONEN J, ANTONEN J et al.: Polymorphism of the tumour necrosis factor-alpha gene at position -308 and renal manifestations of primary Sjögren's syndrome. Rheumatology (Oxford) 2004; 43: 106-7.
8. KOSKI H, JANIN A, HUMPHREYS-BEHER MG, SORSA T, MALMSTRÖM M, KONTTINEN YT: Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjögren's syndrome. Clin Exp Rheumatol 2001; 19: 131-7.
9. TROUSDALE MD, ZHU Z, STEVENSON D, SCHECHTER JE, RITTER T, MIRCHEFF AK: Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J Autoimmune Dis 2005; 2: 6.
10. NORDMARK G, KRISTJANSDOTTIR G, THEANDER E et al.: Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 2011; 12: 100-9.
11. HIGUCHI T, SEKI N, KAMIZONO S et al.: Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-12.
12. WALDRON-LYNCH F, ADAMS C, AMOS C et al.: Tumour necrosis factor 5' promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2001; 2: 82-7.
13. CHEN YC, LIU SF, CHIN CH et al.: Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease. Lung 2010; 188: 339-47.
14. SOHAIL M, KAUL A, BALI P et al.: Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients. Mol Immunol 2008; 45: 1682-92.
15. ELEUTERI E, DI STEFANO A, RICCIARDOLO FL et al.: Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure. Int J Cardiol 2009; 135: 386-90.
16. CEJKOVÁ J, ARDAN T, SIMONOVÁ Z et al.: Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren's syndrome). Nitric Oxide 2007; 17: 10-7.
17. VITALI C, BOMBARDIERI S, JONSSON R et al.: European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
18. MICELI-RICHARD C, GESTERMANN N, ITTAH M et al.: The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis Rheum 2009; 60: 1991-7.
19. NORDMARK G, KRISTJANSDOTTIR G, THEANDER E et al.: Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 2011; 12: 100-9.
20. JONSSON R, MOEN K, VESTRHEIM D, SZODORAY P: Current issues in Sjögren's syndrome. Oral Dis 2002; 8: 130-40.
21. DANIELS TE, WHITCHER JP: Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994; 37: 869-77.
22. AKMAN A, SALLAKCI N, COSKUN M et al.: TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Br J Dermatol 2006; 155: 350-6.
23. SHARMA S, SHARMA A, KUMAR S, SHARMA SK, GHOSH B: Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol 2006; 35: 488-95.
24. TANAKA G, SANDFORD AJ, BURKETT K et al.: Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007; 29: 34-41.
25. WILSON AG, SYMONS JA, MCDOWELL TL, MCDEVITT HO, DUFF GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195-9.
26. POCIOT F, BRIANT L, JONGENEEL CV et al.: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-31.
27. LÚDVÍKSDÓTTIR D, JANSON C, HÖGMAN M et al.: Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group. Bronchial hyperresponsiveness. Eur Respir J 1999; 13: 739-43.
28. WEISS SJ: Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
29. EISERICH JP, BALDUS S, BRENNAN ML et al.: Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296: 2391-4.
30. BALDUS S, EISERICH JP, MANI A et al.: Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001; 108: 1759-70.
31. KURIMOTO C, KAWANO S, TSUJI G et al.: Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. J Rheumatol 2007; 34: 2035-43.
32. BECKMAN JS, BECKMAN TW, CHEN J, MARSHALL PA, FREEMAN BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
33. EISERICH JP, HRISTOVA M, CROSS CE et al.: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-7.
34. CEJKOVÁ J, ARDAN T, SIMONOVÁ Z et al.: Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol 2008; 23: 1477-83.
35. Wu G, FANG YZ, YANG S, LUPTON JR, TURNER ND: Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-92.